• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wockhardt Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt
  • BSE Code : 8021.0
  • ISIN : INE049B01025
1,801.70 -54 (-2.90%)
  • As on 25 Oct 2026 (EOD)

  • Today’s Low

    1,772.00

  • Today’s High

    1,864.00

  • Open

    1,857.00

  • Perv Close

    1,855.50

  • 52W Low

    1,086.70

  • 52W High

    2,422.30

Key Indicators

  • P/E(TTM)

    88.43

  • Mar.Cap (₹Cr.)

    29,276.21

  • Div & Yield %

    0.00

  • Book Value(₹)

    189.81

  • Debt-Equity Ratio

    -2.90

  • AGM Date

    23-Oct-2026

  • EPS

    20.37

  • P/E Ratio

    88.43

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    29,276.21

  • RONW (%)

    -12.34

  • ROCE (%)

    -0.86

Score Board

  • Equity (₹ in Cr.)

    81.25

  • BV (₹)

    189.80

  • Sales( ₹ in Cr.)

    1,739.00

  • NP (in Cr.)

    292.00

  • NP Var(%)

    2533.0

  • Div%

    0.0

  • CPS (₹)

    29.40

  • EPS (₹)

    18.00

  • Traded Value (₹ in Lakhs)

    29,268.90

  • 52 Week High

    2,422.30

  • 52 Week Low

    1,086.70

  • Price BSE

    1801.0

  • Price NSE

    1,802.00

  • Market Capital( in Cr.)

    29,268.90

  • P/C Ratio

    61.20

  • P/E Ratio

    100.20

  • Price Vs.BV

    18.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,739.00 1,402.00 1,154.00 1,072.00 1,372.00 987.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,739.00 1,402.00 1,154.00 1,072.00 1,372.00 987.00
Other Income 162.00 55.00 41.00 67.00 38.00 1,026.00
Stock Adjustments 92.00 46.00 -14.00 -30.00 -2.00 2.00
Total Income 1,993.00 1,503.00 1,181.00 1,109.00 1,408.00 2,015.00
EXPENDITURE :            
Raw Materials 507.00 482.00 447.00 371.00 474.00 418.00
Power and Fuel Cost 73.00 75.00 68.00 54.00 62.00 55.00
Employee Cost 313.00 262.00 247.00 240.00 261.00 293.00
Other Manufacturing Expenses 123.00 96.00 71.00 60.00 94.00 86.00
Selling and Administration Expenses 217.00 179.00 179.00 178.00 181.00 166.00
Miscellaneous Expenses 81.00 54.00 178.00 304.00 76.00 251.00
Employee Benefit Expenses 313.00 262.00 247.00 240.00 261.00 293.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,314.00 1,148.00 1,190.00 1,207.00 1,148.00 1,269.00
Operating Profit 679.00 355.00 -9.00 -98.00 260.00 746.00
Interest 176.00 199.00 237.00 229.00 273.00 200.00
Gross Profit 503.00 156.00 -246.00 -327.00 -13.00 546.00
Depreciation 186.00 168.00 176.00 186.00 171.00 184.00
Profit Before Tax 317.00 -12.00 -422.00 -513.00 -184.00 362.00
Current Tax 0.00 0.00 0.00 0.00 5.00 -136.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 -47.00 -49.00 -95.00
Reported Net Profit 317.00 -12.00 -422.00 -466.00 -140.00 593.00
Extraordinary Items 25.00 0.00 -14.00 -235.00 0.00 -142.00
Adjusted Net Profit 292.00 -12.00 -408.00 -231.00 -140.00 735.00
Adjustment below Net Profit 0.00 0.00 0.00 4.00 -1.00 0.00
P & L Balance brought forward -902.00 -890.00 -468.00 -3.00 138.00 -125.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 330.00
P & L Balance carried down -585.00 -902.00 -890.00 -465.00 -3.00 138.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 19.57 -0.74 -27.40 -32.36 -9.72 53.91
Earnings Per Share(Adj)-Unit Curr 19.57 -0.74 -27.40 -32.36 -9.72 49.68
Book Value 190.37 170.56 116.62 121.74 153.61 146.00
Book Value(Adj)-Unit Curr 190.37 170.56 116.62 121.74 153.61 134.54

Shareholding Pattern

  • Promoter Group

    49.33%

  • Public Share Holding

    50.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,180,051 0.73 1,180,051 6
Partnership Firms-Indian (Promoter & Group) 76,977,915 47.37 76,977,915 4
Persons Acting in Concert 0 0.00 0 0
Trusts 1,991,281 1.23 1,991,281 4
Others 0 0.00 0 0
Sub Total 80,149,247 49.33 80,149,247 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 23,617 0.01 23,617 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 630 0.00 130 4
Foreign Bank 600 0.00 600 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,406,898 7.02 11,405,698 118
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,029,974 1.86 3,028,574 6
Mutual Funds / UTI 9,728,528 5.99 9,728,528 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,858,031 1.14 1,858,031 29
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 26,048,278 16.03 26,045,178 184
2] Non Institution
Bodies Corporate 5,987,894 3.69 5,986,094 1,452
Clearing Members 1,070,909 0.66 1,070,909 91
Directors of their Relatives 295 0.00 295 2
Employees 111,854 0.07 111,854 247
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,160,465 1.33 2,155,665 4,712
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,849,744 1.14 1,849,744 4,440
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,548,002 7.72 12,548,002 81
Individuals holding nominal share capital up to Rs. 1 lakh 31,167,996 19.18 30,832,201 161,737
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,766 0.00 4,766 14
Others 314,493 0.19 314,493 2
Sub Total 56,294,644 34.64 55,952,249 172,918
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 162,492,169 100.00 162,146,674 173,116

Company Background

Wockhardt LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt Ltd
  • BSE Code : 8021.0
  • ISIN : INE049B01025

  • Incorporation Year

    1999

  • Registered Office

    D-4 MIDC
    Chikalthana, AURANGABAD,
    Maharashtra-431006

  • Telephone

    91-240-6694444

  • FAX

    91-240-2489219

  • Chairman

    H F Khorakiwala

  • Managing Director

    Murtaza H Khorakiwala

  • Company Secretary

    Rashmi Mamtura

  • Auditor

    MSKC & Associates LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Wockhardt Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wockhardt 1,801.25 1,876.00 1,739.00 82.21 9.61
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77